Mental health Mental and Behavioural Disorders
Conditions
Interventions
The trial intervention is a training and supervision package for IAPT therapists. The study will receive pseudonymised clinical data for service users on the caseload of a TYPPEX therapist in order to
Sponsors
Cambridgeshire and Peterborough NHS Foundation Trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. IAPT therapist - Training inclusion criteria: 1.1 Qualified Step 3 IAPT CBT therapist 1.2 Willing and able to provide informed consent to receive TYPPEX training and supervision 2. IAPT User - pseudonymised clinical data collection inclusion criteria: 2.1 Accepted onto the IAPT caseload for therapy and therefore meets service specific inclusion criteria to access IAPT treatment 2.2 Assessed for psychotic experiences, according to the presence of a scored Community Assessment of Psychic Experiences (CAPE-P15) questionnaire in their clinical record 3. IAPT User - health economic questionnaires inclusion criteria: 3.1 Meets IAPT service user Eligibility Criteria for pseudonymised clinical data collection 3.2 Presence of psychotic symptoms (according to a Community Assessment of Psychic Experiences (CAPE-P15) questionnaire cut-off value of 1.30 or above on both the frequency and distress sub-scales (hereafter referred to as CAPE+) 3.3 In the judgement of the treating therapist has sufficient proficiency in English to complete research questionnaires
Exclusion criteria
Exclusion criteria: 1. IAPT therapist - Training exclusion criteria: 1.1 Has not completed Step 3 CBT IAPT training. 1.2 Works across more than one locality IAPT team. 1.3 Participated in the earlier TYPPEX WP3d feasibility study. 2. IAPT User - pseudonymised clinical data collection exclusion criteria: 2.1 Presence of mental disorder based on standard IAPT assessment meriting routine referral to National Institute of Clinical Excellence (NICE) step 4 treatment, i.e. to secondary mental health services. 3. IAPT User - health economic questionnaires exclusion criteria: 3.1 None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of CAPE+ caseload who reach IAPT-defined recovery, as calculated from routinely collected outcome data measured at discharge from the IAPT service: 1. Depression measured using the PHQ-9 2. Anxiety measured using GAD-7 3. Anxiety Disorder Specific Measures (there are several ADSMs, and the relevant one is chosen in each case based on the specific type of anxiety being experienced (e.g. OCD, social anxiety, generalised anxiety, etc). | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Cost-effectiveness measured using: participant-reported service use at 3, 6, 9 and 12 months post-baseline, IAPT service costs, and service user IAPT-defined recovery at 1-year post-baseline 2. Health-related Quality of Life (HRQoL) measured using EuroQol EQ-5D-5L and EQ-5D-3L at 3, 6, 9, and 12 months post-baseline 3. Qualitative experiences of health care staff and service users measured using interviews after the first CBT training sessions 4. Therapist adherence measured using a supervision checklist and adherence score completed during the 6 monthly supervision sessions held after CBT training | — |
Countries
England, United Kingdom
Contacts
Public ContactPolly Ashford
Outcome results
None listed